Skip to main content
Premium Trial:

Request an Annual Quote

AP Biotech Acquires Danish Supplier of Protein Synthesis and Separation Equipment

NEW YORK, July 23 – Amersham Pharmacia Biotech has acquired Dan-Process, a Danish supplier of protein synthesis and chromatography systems, from Pantax, its parent company, Amersham said Monday.

Financial details were not disclosed. 

Dan-Process manufactures equipment for the benchtop and large scale synthesis of polypeptides, including fermentation reactors, and chromatography systems for purifying peptides and peptide hormones. 

Peder Dahl, the founder of Dan-Process, will continue to run the day-to-day operations of the company. AP Biotech, of Piscataway, NJ, will sell Dan-Process’ products through its global sales force.

"The acquisition of Dan-Process strengthens our bioprocess portfolio for the purification of peptides and peptide hormones and enhances our ability to offer a complete system solution to our biopharmaceutical customers," Peter Ehrenheim, executive vice president of separations at AP Biotech, said in a statement.

AP Biotech filed for an initial public offering last October, but has postponed the transaction because of market conditions.  
The Scan

Review of Approval Process

Stat News reports the Department for Health and Human Services' Office of the Inspector General is to investigate FDA's approval of Biogen's Alzheimer's disease drug.

Not Quite Right

A new analysis has found hundreds of studies with incorrect nucleotide sequences reported in their methods, according to Nature News.

CRISPR and mRNA Together

Time magazine reports on the use of mRNA to deliver CRISPR machinery.

Nature Papers Present Smartphone Platform for DNA Diagnosis of Malaria, Mouse Lines for Epigenomic Editing

In Nature this week: a low-cost tool to detect infectious diseases like malaria, and more.